Company Overview

Development Stage

About the Company

Labcorp is global leader of innovative comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers patients make clear confident decisions. Through our unparalleled diagnostics drug development laboratory capabilities, our 70,000+ employees combine cutting-edge innovation, science technology to solve some of today’s biggest health challenges, accelerate life-changing healthcare breakthroughs impact lives around the world.

Labcorp is a global top life sciences company, providing vital information to doctors, hospitals, pharmaceutical companies, researchers, and patients to help them make clear and confident decisions. Leveraging our expertise and capabilities in diagnostics and pharmaceutical R&D, Labcorp envisions the future, accelerates innovation, and improves health and lives. When you need information to make clear and confident decisions, Labcorp is your trusted source.

Labcorp is headquartered in Burlington, North Carolina, USA, with over 70,000 employees worldwide, serving clients in more than 100 countries and regions. The company's stock code on the New York Stock Exchange is LH, and it reported revenue of $13.01 billion for the fiscal year 2024. Labcorp participated in the development of over 75% of new drugs approved by the FDA in 2024, and conducted more than 700 million tests for patients worldwide.

About Labcorp China
Labcorp has served the Chinese market for 27 years. The company has established early-stage R&D laboratories, central laboratories, and bioanalytical laboratories in Shanghai, and set up a pharmaceutical R&D innovation base in Suzhou. In addition, combined with Labcorp's central and bioanalytical laboratories in Singapore, as well as its central laboratory in Japan, the company has supported numerous multinational pharmaceutical companies in conducting clinical trials in China over the years, as well as international multi-center clinical trials and new drug applications led by Chinese innovative drug companies.

In Pursuit of Answers
You are welcome to follow our official WeChat public account and video channel - Labcorp. You can visit our official website * or our official channel Labcorp on LinkedIn to learn about our real-time news and business details.
©2025 Labcorp. All rights reserved.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Covance How Fast Is Hiring Growing? (21 open positions)

Manage
Note: How fast is hiring at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd. growing? Covance2026: 41 openings (down 27%), 2025: 56 openings (up 4%), 2024: 54 openings (up 54%), 2023: 35 openings (up 35%), 2022: 26 openings (down 88%), 2021: 210 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Covance Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 80%
  • 2024: Up 400%
Covance Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd. growing? CovanceMaster's recruitment over the years: 2025: 1 openings (down 80%), 2024: 5 openings (up 400%), 2023: 1 openings, 2021: 4 openings.

Covance Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Covance Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd. growing? CovanceDoctorate recruitment over the years: 2026: 1 openings (flat), 2024: 2 openings (up 400%), 2021: 5 openings.

Covance R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd.? Based on an analysis of Covance's job postings over the past year, "生物/制药/化工/环保类" demand: 25%, "医疗卫生/美容保健类": 16.7%, "其他(研发和技术类)": 12.5%, "科研类": 12.5%, "计算机/网络/技术类": 8.3%, "电子/电器/通信技术类": 6.3%. For reference only.

Covance — What Are the Salaries Like? (48 records)

Manage
Covance Salary Overview
salary range: 4.5K - 50K, 50% of roles pay ¥10-20K
Note: salary statistics are based on 48 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd.?Covance50% of positions earn 10-20K, Undergraduate salary: ¥。生物/制药/化工/环保类 average salary ¥16.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Covance

(More)
Are salaries high at Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd.? We provide: 分析,ma,项目协调,研究员,ba,coo,ra,实习生,韩语,pe,临床,日语,项目管理,ea,gis,pr,qa,qc,te,会计. Click to view detailed salary analysis by job.

Covance Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    25% of total 25%
  • 在校学生类
    22.9% of total 22.9%
  • 工厂生产类
    22.9% of total 22.9%
  • 质量管理类
    22.9% of total 22.9%

Education

  • 本科
    79.2% of total 79.2%
  • 不限
    10.4% of total 10.4%
  • 大专
    6.3% of total 6.3%
  • 硕士
    2.1% of total 2.1%

Experience

  • 1-3年
    37.5% of total 37.5%
  • 不限
    33.3% of total 33.3%
  • 3-5年
    20.8% of total 20.8%
  • 5-10年
    8.3% of total 8.3%
View Detailed Analysis

What does Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd. require? Who is Covance hiring? Covance recruitment: 生物/制药/化工/环保类占比最多占25%,其次是在校学生类占22.9%. What education can get in at Covance? 本科占比最多占79.2%,其次是不限占10.4%. High education required at Covance? 硕士占2.1%,博士占2.1%. Work experience required at Covance? 1-3年占比最多占37.5%,其次是不限占33.3%. Where are the job locations at Covance? 上海占比最多占70.8%,其次是苏州占16.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,800万(元)
Legal Representative: FAN JIN
Date Established:
Credit Code: 9131011569582083XW
Registered Address: 中国(上海)自由贸易试验区伽利略路338号9号楼(一照多址企业)

Partners & Suppliers

徕博科为艾昆纬承接的临床试验提供中心实验室检测服务 Source
合作客户 中心实验室
徕博科为阿斯利康提供药物临床试验及研发服务 Source
合作客户 药物研发服务客户
徕博科为默沙东提供新药临床研究服务 Source
合作客户 药物研发服务客户
徕博科为罗氏提供药物临床试验项目服务 Source
合作客户 药物研发服务客户
徕博科为赛诺菲提供临床试验及中心实验室服务 Source
合作客户 药物研发服务客户

People who follow Covance also follow

Covance Competitors (Similar Companies)

医药 药物研发 生物制药 临床前研究
“New drug safety evaluation research institution”
医药 生物制药 药物研发 医药CRO
“肿瘤细胞免疫疗法研发、临床、生产”
健康管理 医疗服务 临床试验 肿瘤治疗
“A large-scale modern integrated Chinese and Western medicine hospital,”
涂料 精细化工 聚合物
医药 药物研发 CRO 制药/药业
连接器 端子 接插件 电力设备
工业自动化 研发 销售 安装
医疗耗材 医疗器械 外科医疗器械 耗材
“A pharmaceutical company dedicated to human biopharmaceutical chemistr”
药物研发 新药研发 临床前研究 临床研究
太阳能电池 太阳能设备 光伏电池 半导体
“Technological innovation and commercial application of pharmaceutical ”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates